ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cytogenetics Market by Product (Consumables, Instruments, and Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, and Others), Application (Genetic Disorders, Cancer, Personalized Medicine, and Others), and End User (Clinical & Research Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025
Published Date: November 2019
|
Report Code: ALLI-Auto-4I279
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Cytogenetics Market by Product Consumables Instruments and Software Services Technique Comparative Genomic Hybridization Fluorescence in Situ Hybridization FISH Karyotyping Immunohistochemistry and Others Application Genetic Disorders Cancer Personalized Medicine and Others and End User Clinical Research Laboratories Pharmaceutical Biotechnology Companies Academic Research Institutes and Others Global Opportunity Analysis and Industry Forecast 2018 2025

Cytogenetics Market by Product (Consumables, Instruments, and Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, and Others), Application (Genetic Disorders, Cancer, Personalized Medicine, and Others), and End User (Clinical & Research Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Code: ALLI-Auto-4I279
Report
November 2019
Pages:185
Allied Market Research
Description
Table of Content

The global cytogenetics market was valued at $1,542 million in 2017 and is projected to reach $3,205 million by 2025 at a CAGR of 9.5% from 2018 to 2025.

 

Cytogenetics is a branch of science, which deals with the study of cytology and genetics in coordination. Cytology includes the study of components of cells such as chromosomes, whereas genetics is the study of arrangement of genes of an individual. Thus, cytogenetics is applied in the detection and treatment of genetic disorders. The detection is based anomalies in the chromosomal patterns such as missing chromosomes, extra chromosomes, and others. These genetic disorders include cancer, cystic fibrosis, sickle cell anemia, Huntington’s disease, and others. Moreover, cytogenetics is an approach used to formulate targeted cancer therapies and personal medicines.

The growth of this market is majorly driven by increase in incidence of genetic disorders and cancer. In addition, rise in focus on targeted cancer treatment, surge in geriatric population, and rise in prevalence of chronic diseases significantly contribute the growth of the market. However, lack of awareness about cytogenetics hinders the growth of the global market. Conversely, high market potential in the untapped emerging economies is anticipated to serve as an attractive opportunity during the forecast period.

The global cytogenetics market is segmented into product, technique, application, end user, and region. On the basis of product, the market is categorized into consumables, instruments, and software & services. By technique, it is divided into comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, immunohistochemistry, and others. The applications covered in this study include genetic disorders, cancer, personalized medicine, and others. Depending on end user, the market is fragmented into clinical & research laboratories, pharmaceutical and biotechnology companies, academic research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

KEY BENEFITS FOR STAKEHOLDERS 

  • The study provides an in-depth analysis of the global cytogenetics market with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
  • A comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on global and regional scales are provided.
  • The profiles of key players and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key market segments

By Product

  • Consumables
  • Testing Kits, Media, and Reagents
  • Probes
  • Others(Affinity Reagents and Stains)
  • Instruments
  • Software & Services 

By Techniques 

  • Comparative Genomic Hybridization
  • Fluorescence in Situ Hybridization
  • Karyotyping
  • Immunohistochemistry
  • Others

 By Application 

  • Genetic Disorders
  • Cancer
  • Personalized Medicine
  • Others 

By End User

 

  • Clinical & Research Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT 

  • Abbott Laboratories Abbott Laboratories
  • Agilent Technologies, Inc.
  • Applied Spectral Imaging, Inc.
  • Empire Genomics, LLC
  • Illumina, Inc.
  • Irvine Scientific.
  • OPKO Health, Inc. (GeneDx.)
  • PerkinElmer Inc.
  • Sysmex Corporation (Oxford Gene Technology)
  • Thermo Fisher Scientific, Inc. 

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.) 

  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd.
  • MetaSystems
Chapter 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Chapter 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/ TOP PLAYER POSITIONING, 2017
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
Chapter 4 CYTOGENETICS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. Consumable
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by product type
4.2.2.1. Testing kits, media, and reagents
4.2.2.1.1. Market size and forecast
4.2.2.2. Probes
4.2.2.2.1. Market size and forecast
4.2.2.3. Others(affinity reagents and stains)
4.2.2.3.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Instrument
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Software & service
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
Chapter 5 CYTOGENETICS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Comparitive genome hybridization
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Fluorescence in situ hybridization
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Karyotyping
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Immunohistochemistry
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Others
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
Chapter 6 CYTOGENETICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Genetic disorder
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Cancer
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Personalized medicine
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Other
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
Chapter 7 CYTOGENETICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Clinical and research laboratory
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. Pharmaceutical and biotechnology company
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. Academic Research Institute
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country
7.5. Other
7.5.1. Market size and forecast, by region
7.5.2. Market analysis, by country
Chapter 8 CYTOGENETICS MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast
8.2.2.1. U.S. market size and forecast
8.2.2.1.1. U.S. market size and forecast, by product
8.2.2.1.2. U.S. market size and forecast, by technique
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user
8.2.2.2. Canada market size and forecast
8.2.2.2.1. Canada market size and forecast, by product
8.2.2.2.2. Canada market size and forecast, by technique
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user
8.2.2.3. Mexico market size and forecast
8.2.2.3.1. Mexico market size and forecast, by product
8.2.2.3.2. Mexico market size and forecast, by technique
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user
8.2.3. North America cytogenetics market, by product
8.2.4. North America cytogenetics market, by technique
8.2.5. North America cytogenetics market, by application
8.2.6. North America cytogenetics market, by end user
8.3. EUROPE
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast
8.3.2.1. Germany market size and forecast
8.3.2.1.1. Germany market size and forecast, by product
8.3.2.1.2. Germany market size and forecast, by technique
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user
8.3.2.2. France market size and forecast
8.3.2.2.1. France market size and forecast, by product
8.3.2.2.2. France market size and forecast, by technique
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user
8.3.2.3. UK market size and forecast
8.3.2.3.1. UK market size and forecast, by product
8.3.2.3.2. UK market size and forecast, by technique
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user
8.3.2.4. Italy market size and forecast
8.3.2.4.1. Italy market size and forecast, by product
8.3.2.4.2. Italy market size and forecast, by technique
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user
8.3.2.5. Spain market size and forecast
8.3.2.5.1. Spain market size and forecast, by product
8.3.2.5.2. Spain market size and forecast, by technique
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user
8.3.2.6. Rest of Europe market size and forecast
8.3.2.6.1. Rest of Europe market size and forecast, by product
8.3.2.6.2. Rest of Europe market size and forecast, by technique
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user
8.3.3. Europe cytogenetics market, by product
8.3.4. Europe cytogenetics market, by technique
8.3.5. Europe cytogenetics market, by application
8.3.6. Europe cytogenetics market, by end user
8.4. ASIA-PACIFIC
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast
8.4.2.1. Japan market size and forecast
8.4.2.1.1. Japan market size and forecast, by product
8.4.2.1.2. Japan market size and forecast, by technique
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user
8.4.2.2. China market size and forecast
8.4.2.2.1. China market size and forecast, by product
8.4.2.2.2. China market size and forecast, by technique
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user
8.4.2.3. India market size and forecast
8.4.2.3.1. India market size and forecast, by product
8.4.2.3.2. India market size and forecast, by technique
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user
8.4.2.4. Australia market size and forecast
8.4.2.4.1. Australia market size and forecast, by product
8.4.2.4.2. Australia market size and forecast, by technique
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user
8.4.2.5. South Korea market size and forecast
8.4.2.5.1. South Korea market size and forecast, by product
8.4.2.5.2. South Korea market size and forecast, by technique
8.4.2.5.3. South Korea market size and forecast, by application
8.4.2.5.4. South Korea market size and forecast, by end user
8.4.2.6. Rest of Asia-Pacific market size and forecast
8.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
8.4.2.6.2. Rest of Asia-Pacific market size and forecast, by technique
8.4.2.6.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.6.4. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific cytogenetics market, by product
8.4.4. Asia-Pacific cytogenetics market, by technique
8.4.5. Asia-Pacific cytogenetics market, by application
8.4.6. Asia-Pacific cytogenetics market, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast
8.5.2.1. Brazil market size and forecast
8.5.2.1.1. Brazil market size and forecast, by product
8.5.2.1.2. Brazil market size and forecast, by technique
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user
8.5.2.2. Saudi Arabia market size and forecast
8.5.2.2.1. Saudi Arabia market size and forecast, by product
8.5.2.2.2. Saudi Arabia market size and forecast, by technique
8.5.2.2.3. Saudi Arabia market size and forecast, by application
8.5.2.2.4. Saudi Arabia market size and forecast, by end user
8.5.2.3. South Africa market size and forecast
8.5.2.3.1. South Africa market size and forecast, by product
8.5.2.3.2. South Africa market size and forecast, by technique
8.5.2.3.3. South Africa market size and forecast, by application
8.5.2.3.4. South Africa market size and forecast, by end user
8.5.2.4. Rest of LAMEA market size and forecast
8.5.2.4.1. Rest of LAMEA market size and forecast, by product
8.5.2.4.2. Rest of LAMEA market size and forecast, by technique
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user
8.5.3. LAMEA cytogenetics market, by product
8.5.4. LAMEA cytogenetics market, by technique
8.5.5. LAMEA cytogenetics market, by application
8.5.6. LAMEA cytogenetics market, by end user
Chapter 9 COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. Agilent Technologies, Inc.
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. Applied Spectrial Imaging, Inc.
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. Empire Genomics, LLC
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. Illumina, Inc.
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. Irvine Scientific
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. OPKO Health, Inc.
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. PerkinElmer, Inc.
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. Sysmex Corporation
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and development
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5370

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$6450

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8995

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT
HAVE A QUERY?
INQUIRE ABOUT REPORT EMAIL US
OUR CUSTOMER
Strategic Venue Partners
SIMILAR REPORTS
Cytogenetics Market by Product Consumables Instruments and Software Services Technique Comparative Genomic Hybridization Fluorescence in Situ Hybridization FISH Karyotyping Immunohistochemistry and Others Application Genetic Disorders Cancer Personalized Medicine and Others and End User Clinical Research Laboratories Pharmaceutical Biotechnology Companies Academic Research Institutes and Others Global Opportunity Analysis and Industry Forecast 2018 2025
Human Genetics Market
Global Animal Genetics Market Size Status and Forecast 2019 2025
Optogenetics Market
Global Gene Expression Market Size Status and Forecast 2019 to 2025
Global United States European Union and China Genotyping Market Research Report 2019 2025
Global Gene Therapy Market Premium Insight Competitive News Feed Analysis Company Usability Profiles Market Sizing Forecasts to 2025
Cell Culture Media Market
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Plant-based Soft Capsule - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26V13549
Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Grade Sodium Hyaluronate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17N14065
Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Fluid Bed System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-6Q14792
Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Medical Microbial Incubators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-30W13258
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICIES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions